key: cord-0945307-bgi0byzy authors: Safa, Omid; Hassani-Azad, Mehdi; Farashahinejad, Mehdi; Davoodian, Parivash; Dadvand, Habib; Hassanipour, Soheil; Fathalipour, Mohammad title: Effects of Licorice on clinical symptoms and laboratory signs in moderately ill patients with pneumonia from COVID-19: A structured summary of a study protocol for a randomized controlled trial date: 2020-09-15 journal: Trials DOI: 10.1186/s13063-020-04706-3 sha: 13eba8b56a982378de82f93804458b90f3c862cb doc_id: 945307 cord_uid: bgi0byzy OBJECTIVES: We investigate the effects of Licorice (Glycyrrhiza glabra L.) root extract, an anti-inflammatory natural medicine, compared to the usual therapeutic regimen on clinical symptoms and laboratory signs in patients with confirmed COVID-19 that are moderately ill. TRIAL DESIGN: This is a single-center, open-label, randomized, clinical trial with parallel-group design. This study is being conducted at Shahid Mohammadi Hospital, Bandar Abbas, Iran. PARTICIPANTS: Both male and female patients with ≥18 years of age (≥ 35 kg of weight), admitted at the Shahid Mohammadi Hospital, Hormozgan University of Medical Sciences, Bandar Abbas for treatment, screened for the following criteria. Inclusion criteria: 1. Confirmed diagnosis of SARS-CoV-2 infection (via polymerase chain reaction [PCR] and/or antibody test). 2. Presenting as moderate COVID-19 pneumonia (via chest computed tomography (CT) and/or X-ray) requiring hospitalization. 3. Hospitalized ≤48 hours. 4. Signing informed consent and willingness of study participant to accept randomization to any assigned treatment arm. Exclusion criteria: 1. Underlying diseases, including chronic heart disease, chronic hypertension, severe renal failure, severe liver failure, and thyroid disorders. 2. Severe and critical COVID-19 pneumonia. 3. Use of warfarin, selective serotonin reuptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs), diuretics, corticosteroids, and antiarrhythmic drugs. 4. Treatment with Investigational and antiviral therapy in a clinical study within one month before randomization. 5. History of allergy to Licorice. 6. Pregnancy and breastfeeding. INTERVENTION AND COMPARATOR: Intervention group: The standard treatment regimen for COVID-19 along with a Licorice-based herbal preparation (D-Reglis ®, Irandarouk Pharmaceutical Company, Iran) at a dose of 760 mg three times a day for a period of seven days. Control group: The standard treatment for COVID-19 based on the Iranian Ministry of Health and Medical Education's protocol for a period of seven days. MAIN OUTCOMES: The recovery rate of clinical symptoms, including fever, dry cough, and tiredness, as well as paraclinical features, including thrombocytopenia, lymphocytopenia, and C-reactive protein, are evaluated as primary outcomes within seven days of randomization. Time to improvement of clinical and paraclinical features and length of stay in a hospital, along with the incidence of adverse reactions are also evaluated as the secondary outcomes within seven days of randomization. RANDOMIZATION: An electronic table of random numbers will be used to allocate the included participants into either control or intervention groups (in a 1:1 ratio) using the simple randomization method. BLINDING (MASKING): This is an open-label trial without blinding and placebo control. NUMBERS TO BE RANDOMIZED (SAMPLE SIZE): A total of 60 participants randomizes (30 patients allocated to the intervention group and 30 patients allocated to the control group). TRIAL STATUS: The protocol is Version 1.0, May 31, 2020. Recruitment began July 30, 2020, and is anticipated to be completed by October 30, 2020. TRIAL REGISTRATION: This clinical trial has been registered in the Iranian Registry of Clinical Trials (IRCT). The registration number is “IRCT20200506047323N2”, https://www.irct.ir/trial/47990. The registration date is 31 May 2020. FULL PROTOCOL: The full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest in expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol. Despite the large number of study carried out on the coronavirus disease 2019 (COVID- 19) , no effective pharmacological agents have yet been proven for the treatment of patients. Licorice (Glycyrrhiza glabra L.) is a strong demulcent that had been effectively used in the management of a number of diseases. The aim of the present study is to investigate the effects of Licorice root extract on clinical symptoms and laboratory signs in patients with covid- 19 . A perspective open-label randomized clinical trial will be conducted on 60 hospitalized adult patients with covid-19 positive test (polymerase chain reaction test or chest CT-scan). Patients were randomly assigned in a 1:1 ratio to receive either Licorice root extract (760 mg three times a day) and standard care (lopinavir-ritonavir 200/50 mg twice a day and hydroxychloroquine 200 mg twice a day) for seven days, or standard care alone. The primary outcomes are defined as recovery rate of clinical symptoms, including fever, high respiratory rate, low oxygen saturation, cough, myalgia, Headache, apnea, weakness, diarrhea, abdominal cramps, nausea, and vomiting. Secondary outcomes include the time from randomization to fever reduction and cough relief as well as the rate of oxygen therapy or noninvasive mechanical ventilation during the trial. Complete blood count and serum biochemical parameters will be checked on the first and seventh days. The adverse events and the diagnostic test will be evaluated at the end of study. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and corona virus disease-2019 (COVID-19): the epidemic and the challenges A review of the 2019 Novel Coronavirus (COVID-19) based on current evidence WHO Director-General's opening remarks at the media briefing on COVID-19-11 What We Know So Far About New Coronavirus (COVID-19) COVID-19 Coronavirus Disease Loss of sense of smell as marker of COVID-19 infection. ENT UK at The Royal College of Surgeons of England The COVID-19 epidemic The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Chloroquine for the 2019 novel coronavirus Liquorice, a unique "guide drug" of traditional Chinese medicine: a review of its role in drug interactions Antitussive and expectorant activities of licorice and its major compounds Liquorice (Glycyrrhiza glabra): A phytochemical and pharmacological review Effect of licorice on PTH levels in healthy women Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds Antiulcerogenic effect of some gastrointestinally acting plant extracts and their combination Mode of antibacterial action of retrochalcones from Glycyrrhiza inflata Anti-Helicobacter pylori flavonoids from licorice extract. Life sciences Antiulcer properties of Glycyrrhiza glabra L. extract on experimental models of gastric ulcer in mice Antioxidant effect of licorice root on blood catalase activity in vibration stress European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP) The core structure and immunological activities of glycyrrhizan UA, the main polysaccharide from the root of Glycyrrhiza uralensis. Chemical and pharmaceutical bulletin Effects of glycyrrhizin on UVB-irradiated melanoma cells. in vivo Isoliquiritigenin inhibits cell proliferation and induces apoptosis in human hepatoma cells Isoliquiritigenin induces apoptosis by depolarizing mitochondrial membranes in prostate cancer cells Glycyrrhiza glabra) and the adrenal-kidney-pituitary axis in rats Effect of glycyrrhizine on hyperkalemia due to hyporeninemic hypoaldosteronism in diabetes mellitus Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice Hypocholesterolaemic and antioxidant effects of Glycyrrhiza glabra (Linn) in rats. Molecular nutrition & food research Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid Antithrombotic effect of Glycyrrhizin, a plant-derived thrombin inhibitor Identification of glycyrrhizin as a thrombin inhibitor Pharmacological study of the anti-inflammatory agent glyderinine The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro Therapeutic basis of glycyrrhizin on chronic hepatitis B Antiviral and immune stimulant activities of glycyrrhizin against duck hepatitis virus Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus The long term efficacy of glycyrrhizin in chronic hepatitis C patients Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus Review of Antiviral Effects of Glycyrrhiza glabra L. and Its Active Component The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: A randomized controlled clinical trial To evaluate of the effect of adding licorice to the standard treatment regimen of Helicobacter pylori Efficacy of oral administration of licorice as an adjunct therapy on improving the symptoms of patients with Parkinson's disease, A randomized double blinded clinical trial The effects of licorice flavonoid oil with respect to increasing muscle mass: a randomized, double-blind, placebo-controlled trial The effects of dietary licorice flavonoid oil supplementation on body balance control in healthy middle-aged and older Japanese women undergoing a physical exercise intervention: a randomized, double-blind, placebocontrolled trial Changes of insulin resistance and adipokines following supplementation with Glycyrrhiza glabra L. Extract in combination with a low-calorie diet in overweight and obese subjects: A randomized double blind clinical trial Effects of dried licorice extract with low-calorie diet on lipid profile and atherogenic indices in overweight and obese subjects: A randomized controlled clinical trial The effect of Glycyrrhiza glabra L. On primary dysmenorrhea compared with ibuprofen: A randomized, triple-blind controlled trial Impact of Glycyrrhiza glabra (licorice) vaginal cream on vaginal signs and symptoms of vaginal atrophy in postmenopausal women: A randomized double blind controlled trial Evaluation of anti-inflammatory effect of oral licorice in comparison with chlorhexidine in population with gingivitis: A double blind clinical trial study Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy-induced oral mucositis: A randomized double-blinded clinical trial Effects of mouthwash interventions on xerostomia and unstimulated whole saliva flow rate among hemodialysis patients: A randomized controlled study The treatment of atopic dermatitis with licorice gel Effective treatment for sensitive skin: 4-t-butylcyclohexanol and licochalcone A Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo A controlled trial of a dissolving oral patch concerning glycyrrhiza (licorice) herbal extract for the treatment of aphthous ulcers